ECHOIQ LIMITED — Capital/Financing Update 2020

May 5, 2020

==> picture [133 x 75] intentionally omitted <==

ASX:HWH RELEASE / 6 MAY 2020

NEW CONTRACT WINS AND EXPANSIONS VALIDATE GROWTH STRATEGY

• New contract wins and expansions secured in the current quarter with customers predominantly in the healthcare sector

• Collectively delivers $130,000 in added revenue which is likely to grow

• Driven by successful cross-selling of the HWH and Prometheus technology suite and clearly validates Prometheus acquisition

• Opportunity pipeline is strengthening as companies in multiple sectors seek more robust AI and prescriptive analytics solutions in current market

Sydney,Australia:PrescriptiveAnalyticsandAICompany,HoustonWeHave
Limited(“HoustonWeHave”,the“Company”)(ASX:HWH),ispleasedtoreport
thatithassecurednewcontractwinsandexpansionsofexistingcontracts
with clients predominantly in the healthcare sector.

Collectively,thecontractsdeliver$130,000ofrevenue,whichcouldgrow
furtherasprojectsprogress.Whiletheassociatedrevenueisinitially
modest,thekeytakeoutfortheCompanyisthatithasbeensuccessfulin
cross-sellingacomplimentarysuiteofprescriptiveanalyticsandAIservices
thattheintegratedHoustonWeHaveandPrometheusisnowmarketing.
Prometheusgeneratesrecurringannualsubscriptionrevenuefromhealthfund
clients for software modules accessed.

ItisalsoastrongvalidationofthePrometheusacquisitionandshowsthat
thego-to-marketstrategyisyieldingtangibleresults.Clientsareclearly
buying into the value proposition. Contracts include:

• A partnership where the Queensland Country Health Fund Ltd is deploying, a phased approach, the Company’s Intelfuze Augmented Intelligence technology;

• Recent client Australian Regional Health Group Ltd (ARHG) goes live this week with Prometheus analytical and reporting solutions to drive greater insight and better outcomes for its health fund customers;

• Extensions to the ancillary fraud module to assist health funds better understand provider behaviour during the COVID-19 period;

• COVID-19 specific reporting for Health Fund clients to assess the impact COVID-19 on members and service levels.

Houston We Have Ltd. ACN 142 901 353. 3/33 Atchison Street St Leonards NSW Australia +61 2 9159 3719
Sydney> Canberra> Adelaide> Perth> Edinburgh. Human-Centred AI. Problem solved.

==> picture [124 x 69] intentionally omitted <==

Management commentary:

ManagingDirectorandCEOElizabethWhitelocksaid:“HoustonWeHaveis
witnessinggrowingdemandforitsbroadersuiteofPrescriptiveAnalytics
AItechnologysolutionsasmoreclientsrecognisetheclearcommercial
benefitsthattheydeliver.Thecross-sellingsynergieswepromisedfrom
Prometheusacquisitionarenowmaterialingandweanticipatemorecontract
wins and extensions to be locked in as a result.

“Whilstallthesecontractwinsandexpansionsarevalued,partneringwith
QueenslandCountryHealthFundisahighlightgivenitisanexisting
Prometheusclientthathasboughtintoourbroadersolutionandwillsurely
benefit from the expanded capability we are delivering.

“Asmorecompaniesnavigatetheirwaythroughthecurrentmarketandchanging
consumerbehaviour,weconfidentlyexpectthatourpipelineofopportunity
tenderswillcontinuetogrowasaresult.Assuch,weexpecttoreportmore
of the same very soon.”

ENDS

Elizabeth Whitelock
Managing Director and CEO
Houston We Have Ltd.

Authorised for release by the Board of Directors of Houston We Have Ltd

For more information, please contact: investor@HoustonWeHave.ai

ABOUT US: Houston we have Human-Centred AI. As a team, we set out to enhance decision
making: Augmented Intelligence gives humans the ability to predict the future
at speed and without bias.Military grade, originally designed and built for the
intelligence community, our patented software delivers insights beyond any AI in the
universe. Now available for use by all clever humans. HoustonWeHave.ai problem solved